Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-2543-2025

Philips Medical Systems Nederland B.V. recalls IntelliSpace Cardiovascular

Philips Medical Systems Nederland B.V.Eindhoven, NetherlandsReported Sep 17, 2025 · 10 months ago
Legal News Analyst ·

Reason for recall

Software issue that results in the display of outdated information.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

IntelliSpace Cardiovascular, Software 8.0.0.4.

Lot / code information

Model
830089
UDI
(01)00884838122000(11)240325(10)8.0.0.0
Serial #
2210, 2050, 463, 193

What the firm is doing

An URGENT Medical Device Correction notice dated 8/7/25 was mailed to consignees. The notification includes instructions for continued safe use of devices, which includes: 1. Ensure all finding codes with variables/modifiers are populated correctly on the report screen. Do not leave any FitB Modifier Code Fields Blank. 2. Verify report statements match the selections in the work area before finalizing report. Systems may continue to be used in accordance with the intended use and per the additional instructions. The provided recall notification is to be shared with all users of the device and retained with affected systems until the corrected software is installed. The provided recall response form should be returned within 30 days to Philips.recall@Philips.com. A Philips representative will call consignees to schedule a time to install the software solution (FCO83000218). Consignees with any questions can contact Philips Informatics Customer Support at 1-800-996-1328 (x1).

DistributionShow details

US Nationwide distribution in the states of GA, NC & TX.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls